Loading insider details...
Beta
Latest Form 4 (Sep 22, 2026): Exercise/Conversion of 264 GH shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 264 | n/a |
| Sep 22, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale | 367,600 | $14.36M |
| Aug 24, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 264 | n/a |
| Jul 22, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 264 | n/a |
| Jun 23, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 264 | n/a |
| Jun 22, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 4,203 | n/a |
| Jun 8, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 14,492 | n/a |
| Jun 1, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/Award | 7,242 | n/a |
| Apr 22, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 264 | n/a |
| Mar 23, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 264 | n/a |